Skip to main content
Top
Published in:

Open Access 01-12-2024 | Research

Translation and validation of the caffeine use disorder questionnaire in Arabic

Authors: Feten Fekih-Romdhane, Rabih Hallit, Diana Malaeb, Fouad Sakr, Mariam Dabbous, Sahar Obeid, Souheil Hallit

Published in: Archives of Public Health | Issue 1/2024

Login to get access

Abstract

Background

Due to the elevated global prevalence of its consumption, and the detrimental health effects it can have, caffeine use disorder (CUD) should receive a great deal of attention from clinicians and the research community in Arab countries as an area of concern. To help advance the field, this study aimed to translate the Caffeine Use Disorder Questionnaire (CUDQ) into the Arabic language, and examine its psychometric properties in community adults.

Methods

A descriptive, observational and cross-sectional study was carried out during the period from May to July 2024. Arabic-speaking adults from the general population of Lebanon (N = 1858, 49.8% males, mean age of 30.05 ± 11.39 years), reporting caffeine consumption at least once during the last 12 months, were included.

Results

The study’s results provided support to the theoretical assumptions of unidimensionality of the original version of the CUDQ, with excellent composite reliability (Cronbach’s α = 0.90). Furthermore, the structure of the Arabic CUDQ was equivalent across sex, suggesting that the latent CUD construct has the same meaning in male and female adults. The highest CUDQ scores were reported by participants drinking 7 to 9 cups and 10 cups or more of coffee/per day relative to those consuming lower amounts of coffee. Finally, our findings revealed good concurrent validity based on positive correlations of CUDQ scores with nicotine dependence, depression and anxiety scores.

Conclusion

Overall, findings suggest that the CUDQ is appropriate and suitable for use to measure CUD among Arabic-speaking adults from the general population. Making the CUDQ available in the Arabic language can fill a gap in the assessment of problematic caffeine consumption in Arab contexts. Future studies are required to further confirm the psychometric soundness of the Arabic CUDQ in more representative samples, specific populations and other Arab countries.
Literature
1.
go back to reference Quadra GR et al. Caffeine Consumption over Time, in Handbook of Substance Misuse and Addictions: From Biology to Public Health, V.B. Patel and V.R. Preedy, Editors. 2022, Springer International Publishing: Cham. pp. 1535–1552. Quadra GR et al. Caffeine Consumption over Time, in Handbook of Substance Misuse and Addictions: From Biology to Public Health, V.B. Patel and V.R. Preedy, Editors. 2022, Springer International Publishing: Cham. pp. 1535–1552.
2.
go back to reference Spiller MA.The chemical components of coffee.Caffeine, 2019:97–161. Spiller MA.The chemical components of coffee.Caffeine, 2019:97–161.
3.
go back to reference Verster JC, Koenig J. Caffeine intake and its sources: a review of national representative studies. Crit Rev Food Sci Nutr. 2018;58(8):1250–9.PubMedCrossRef Verster JC, Koenig J. Caffeine intake and its sources: a review of national representative studies. Crit Rev Food Sci Nutr. 2018;58(8):1250–9.PubMedCrossRef
4.
go back to reference Butt MS, Sultan MT. Coffee and its consumption: benefits and risks. Crit Rev Food Sci Nutr. 2011;51(4):363–73.PubMedCrossRef Butt MS, Sultan MT. Coffee and its consumption: benefits and risks. Crit Rev Food Sci Nutr. 2011;51(4):363–73.PubMedCrossRef
6.
go back to reference Grosso G, et al. Coffee, Caffeine, and Health outcomes: an Umbrella Review. Annu Rev Nutr. 2017;37:131–56.PubMedCrossRef Grosso G, et al. Coffee, Caffeine, and Health outcomes: an Umbrella Review. Annu Rev Nutr. 2017;37:131–56.PubMedCrossRef
7.
go back to reference Reddy VS, et al. Pharmacology of caffeine and its effects on the human body. Eur J Med Chem Rep. 2024;10:100138. Reddy VS, et al. Pharmacology of caffeine and its effects on the human body. Eur J Med Chem Rep. 2024;10:100138.
8.
go back to reference Derry CJ, Derry S, Moore RA. Caffeine as an analgesic adjuvant for acute pain in adults. Cochrane Database Syst Reviews, 2014(12). Derry CJ, Derry S, Moore RA. Caffeine as an analgesic adjuvant for acute pain in adults. Cochrane Database Syst Reviews, 2014(12).
9.
go back to reference Ding M, et al. Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation. 2014;129(6):643–59.PubMedCrossRef Ding M, et al. Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation. 2014;129(6):643–59.PubMedCrossRef
10.
11.
go back to reference Pohler H. Caffeine intoxication and addiction. J Nurse Practitioners. 2010;6(1):49–52.CrossRef Pohler H. Caffeine intoxication and addiction. J Nurse Practitioners. 2010;6(1):49–52.CrossRef
13.
go back to reference World Health Organization. ICD-11, the 11th Revision of the International Classification of Diseases; 2022. World Health Organization. ICD-11, the 11th Revision of the International Classification of Diseases; 2022.
14.
go back to reference American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. Volume 5. American psychiatric association Washington, DC; 2013. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. Volume 5. American psychiatric association Washington, DC; 2013.
15.
go back to reference American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed., text rev.); 2022. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th ed., text rev.); 2022.
16.
go back to reference Sweeney MM, et al. Prevalence and correlates of caffeine use disorder symptoms among a United States sample. J Caffeine Adenosine Res. 2020;10(1):4–11.PubMedPubMedCentralCrossRef Sweeney MM, et al. Prevalence and correlates of caffeine use disorder symptoms among a United States sample. J Caffeine Adenosine Res. 2020;10(1):4–11.PubMedPubMedCentralCrossRef
18.
go back to reference Sweeney MM, et al. A randomized controlled trial of a manual-only treatment for reduction and cessation of problematic caffeine use. Drug Alcohol Depend. 2019;195:45–51.PubMedCrossRef Sweeney MM, et al. A randomized controlled trial of a manual-only treatment for reduction and cessation of problematic caffeine use. Drug Alcohol Depend. 2019;195:45–51.PubMedCrossRef
19.
go back to reference Evatt DP, Juliano LM, Griffiths RR. A brief manualized treatment for problematic caffeine use: a randomized control trial. J Consult Clin Psychol. 2016;84(2):113.PubMedCrossRef Evatt DP, Juliano LM, Griffiths RR. A brief manualized treatment for problematic caffeine use: a randomized control trial. J Consult Clin Psychol. 2016;84(2):113.PubMedCrossRef
20.
go back to reference Jones HA, Lejuez C. Personality correlates of caffeine dependence: the role of sensation seeking, impulsivity, and risk taking. Exp Clin Psychopharmacol. 2005;13(3):259.PubMedCrossRef Jones HA, Lejuez C. Personality correlates of caffeine dependence: the role of sensation seeking, impulsivity, and risk taking. Exp Clin Psychopharmacol. 2005;13(3):259.PubMedCrossRef
21.
go back to reference Svikis DS, et al. Caffeine dependence in combination with a family history of alcoholism as a predictor of continued use of caffeine during pregnancy. Am J Psychiatry. 2005;162(12):2344–51.PubMedCrossRef Svikis DS, et al. Caffeine dependence in combination with a family history of alcoholism as a predictor of continued use of caffeine during pregnancy. Am J Psychiatry. 2005;162(12):2344–51.PubMedCrossRef
22.
go back to reference LM J, Anderson BL.Griffiths RR. Caffeine.Strain. E., editor. Lowinson & Ruiz’s substance abuse: a Comprehensive Textbook. Fifth. Philadelphia: Lippincott Williams & Wilkins; 2011. pp. 335–53. LM J, Anderson BL.Griffiths RR. Caffeine.Strain. E., editor. Lowinson & Ruiz’s substance abuse: a Comprehensive Textbook. Fifth. Philadelphia: Lippincott Williams & Wilkins; 2011. pp. 335–53.
23.
go back to reference Ágoston C, et al. Caffeine use disorder: An item-response theory analysis of proposed DSM-5 criteria. Addict Behav. 2018;81:109–16.PubMedCrossRef Ágoston C, et al. Caffeine use disorder: An item-response theory analysis of proposed DSM-5 criteria. Addict Behav. 2018;81:109–16.PubMedCrossRef
24.
go back to reference Kaya S et al. Validation of the Turkish version of the caffeine use disorder questionnaire in an adult population. Int J Mental Health Addict, 2021;1–12. Kaya S et al. Validation of the Turkish version of the caffeine use disorder questionnaire in an adult population. Int J Mental Health Addict, 2021;1–12.
25.
go back to reference Abdoli F, et al. Estimate the prevalence of daily caffeine consumption, caffeine use disorder, caffeine withdrawal and perceived harm in Iran: a cross-sectional study. Sci Rep. 2024;14(1):7644.PubMedPubMedCentralCrossRef Abdoli F, et al. Estimate the prevalence of daily caffeine consumption, caffeine use disorder, caffeine withdrawal and perceived harm in Iran: a cross-sectional study. Sci Rep. 2024;14(1):7644.PubMedPubMedCentralCrossRef
27.
go back to reference Amer SA, et al. Caffeine addiction and determinants of caffeine consumption among health care providers: a descriptive national study. Volume 27. European Review for Medical & Pharmacological Sciences; 2023;8. Amer SA, et al. Caffeine addiction and determinants of caffeine consumption among health care providers: a descriptive national study. Volume 27. European Review for Medical & Pharmacological Sciences; 2023;8.
28.
go back to reference Alaa Hammami MB, et al. Caffeine consumption levels and knowledge among adults in the United Arab Emirates: insights from a nationwide survey. J Caffeine Adenosine Res. 2018;8(2):71–9.CrossRef Alaa Hammami MB, et al. Caffeine consumption levels and knowledge among adults in the United Arab Emirates: insights from a nationwide survey. J Caffeine Adenosine Res. 2018;8(2):71–9.CrossRef
29.
go back to reference Makki NM, et al. Caffeine Consumption and Depression, Anxiety, and Stress Levels Among University Students in Medina: A Cross-Sectional Study. Cureus. 2023;15(10):e48018.PubMedPubMedCentral Makki NM, et al. Caffeine Consumption and Depression, Anxiety, and Stress Levels Among University Students in Medina: A Cross-Sectional Study. Cureus. 2023;15(10):e48018.PubMedPubMedCentral
30.
go back to reference Samaha A, et al. Data on the relationship between caffeine addiction and stress among Lebanese medical students in Lebanon. Data Brief. 2020;28:104845.PubMedCrossRef Samaha A, et al. Data on the relationship between caffeine addiction and stress among Lebanese medical students in Lebanon. Data Brief. 2020;28:104845.PubMedCrossRef
31.
go back to reference Kukhareva E. A drink for the Soul: the Coffee tree and Coffee as a Symbol of the Arab National Mentality. Russian J Cult Stud Communication. 2024;2(1):14–28.CrossRef Kukhareva E. A drink for the Soul: the Coffee tree and Coffee as a Symbol of the Arab National Mentality. Russian J Cult Stud Communication. 2024;2(1):14–28.CrossRef
32.
go back to reference AL-Asmari KM, Zeid IMA, Al-Attar AM. Coffee arabica in Saudi Arabia: an overview. Int J Pharm Phytopharmacological Res (eIJPPR). 2020;10(4):71–8. AL-Asmari KM, Zeid IMA, Al-Attar AM. Coffee arabica in Saudi Arabia: an overview. Int J Pharm Phytopharmacological Res (eIJPPR). 2020;10(4):71–8.
33.
go back to reference Van Widenfelt BM, et al. Translation and cross-cultural adaptation of assessment instruments used in psychological research with children and families. Clin Child Fam Psychol Rev. 2005;8:135–47.PubMedCrossRef Van Widenfelt BM, et al. Translation and cross-cultural adaptation of assessment instruments used in psychological research with children and families. Clin Child Fam Psychol Rev. 2005;8:135–47.PubMedCrossRef
34.
go back to reference Ambuehl B, Inauen J. Contextualized measurement scale adaptation: a 4-Step tutorial for health psychology research. Int J Environ Res Public Health. 2022;19(19):12775.PubMedPubMedCentralCrossRef Ambuehl B, Inauen J. Contextualized measurement scale adaptation: a 4-Step tutorial for health psychology research. Int J Environ Res Public Health. 2022;19(19):12775.PubMedPubMedCentralCrossRef
35.
go back to reference Heatherton TF, et al. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991;86(9):1119–27.PubMedCrossRef Heatherton TF, et al. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991;86(9):1119–27.PubMedCrossRef
36.
go back to reference Kassim S, Salam M, Croucher R. Validity and reliability of the Fagerstrom Test for Cigarette Dependence in a sample of Arabic speaking UK-resident Yemeni khat chewers. Asian Pac J Cancer Prev. 2012;13(4):1285–8.PubMedCrossRef Kassim S, Salam M, Croucher R. Validity and reliability of the Fagerstrom Test for Cigarette Dependence in a sample of Arabic speaking UK-resident Yemeni khat chewers. Asian Pac J Cancer Prev. 2012;13(4):1285–8.PubMedCrossRef
38.
go back to reference Sawaya H, et al. Adaptation and initial validation of the Patient Health Questionnaire – 9 (PHQ-9) and the Generalized Anxiety Disorder – 7 Questionnaire (GAD-7) in an Arabic speaking Lebanese psychiatric outpatient sample. Psychiatry Res. 2016;239:245–52.PubMedCrossRef Sawaya H, et al. Adaptation and initial validation of the Patient Health Questionnaire – 9 (PHQ-9) and the Generalized Anxiety Disorder – 7 Questionnaire (GAD-7) in an Arabic speaking Lebanese psychiatric outpatient sample. Psychiatry Res. 2016;239:245–52.PubMedCrossRef
39.
go back to reference Dagher D, et al. Depressive symptoms among a sample of Lebanese adolescents: Scale validation and correlates with disordered eating. Arch Pediatr. 2023;30(6):401–7.PubMedCrossRef Dagher D, et al. Depressive symptoms among a sample of Lebanese adolescents: Scale validation and correlates with disordered eating. Arch Pediatr. 2023;30(6):401–7.PubMedCrossRef
40.
go back to reference Spitzer RL, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.PubMedCrossRef Spitzer RL, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7.PubMedCrossRef
41.
go back to reference El Khoury-Malhame M et al.Psychometric validation of the Arabic version of the GAD-7 among Lebanese Adolescents.2024. El Khoury-Malhame M et al.Psychometric validation of the Arabic version of the GAD-7 among Lebanese Adolescents.2024.
42.
go back to reference Mundfrom DJ, Shaw DG, Ke TL. Minimum sample size recommendations for conducting factor analyses. Int J Test. 2005;5(2):159–68.CrossRef Mundfrom DJ, Shaw DG, Ke TL. Minimum sample size recommendations for conducting factor analyses. Int J Test. 2005;5(2):159–68.CrossRef
43.
go back to reference Hu Lt, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Struct equation modeling: multidisciplinary J. 1999;6(1):1–55.CrossRef Hu Lt, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Struct equation modeling: multidisciplinary J. 1999;6(1):1–55.CrossRef
44.
go back to reference Chen FF. Sensitivity of goodness of fit indexes to lack of measurement invariance. Struct equation modeling: multidisciplinary J. 2007;14(3):464–504.CrossRef Chen FF. Sensitivity of goodness of fit indexes to lack of measurement invariance. Struct equation modeling: multidisciplinary J. 2007;14(3):464–504.CrossRef
45.
go back to reference Vadenberg R, Lance C. A review and synthesis of the measurement in variance literature: Suggestions, practices, and recommendations for organizational research. Organ Res Methods. 2000;3:4–70.CrossRef Vadenberg R, Lance C. A review and synthesis of the measurement in variance literature: Suggestions, practices, and recommendations for organizational research. Organ Res Methods. 2000;3:4–70.CrossRef
46.
go back to reference Swami V, et al. Psychometric properties of an Arabic translation of the Functionality Appreciation Scale (FAS) in Lebanese adults. Body Image. 2022;42:361–9.PubMedCrossRef Swami V, et al. Psychometric properties of an Arabic translation of the Functionality Appreciation Scale (FAS) in Lebanese adults. Body Image. 2022;42:361–9.PubMedCrossRef
47.
go back to reference Hair JF Jr, et al. Advanced issues in partial least squares structural equation modeling. saGe; 2017. Hair JF Jr, et al. Advanced issues in partial least squares structural equation modeling. saGe; 2017.
48.
go back to reference Association AP. Publication manual of the American psychological association (7th ed.). 2020: Washington DC, USA. Association AP. Publication manual of the American psychological association (7th ed.). 2020: Washington DC, USA.
50.
go back to reference Pray L, Yaktine AL, Pankevich D. Caffeine in food and dietary supplements: examining safety. Workshop summary; 2014. Pray L, Yaktine AL, Pankevich D. Caffeine in food and dietary supplements: examining safety. Workshop summary; 2014.
51.
go back to reference Lieberman HR, Agarwal S, Fulgoni VL. Daily Patterns of Caffeine Intake and the Association of Intake with Multiple Sociodemographic and Lifestyle Factors in US Adults Based on the NHANES 2007–2012 Surveys. J Acad Nutr Dietetics. 2019;119(1):106–14.CrossRef Lieberman HR, Agarwal S, Fulgoni VL. Daily Patterns of Caffeine Intake and the Association of Intake with Multiple Sociodemographic and Lifestyle Factors in US Adults Based on the NHANES 2007–2012 Surveys. J Acad Nutr Dietetics. 2019;119(1):106–14.CrossRef
52.
53.
Metadata
Title
Translation and validation of the caffeine use disorder questionnaire in Arabic
Authors
Feten Fekih-Romdhane
Rabih Hallit
Diana Malaeb
Fouad Sakr
Mariam Dabbous
Sahar Obeid
Souheil Hallit
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Archives of Public Health / Issue 1/2024
Electronic ISSN: 2049-3258
DOI
https://doi.org/10.1186/s13690-024-01447-6

Keynote webinar | Spotlight on adolescent vaping

  • Live
  • Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET
 

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Join the webinar

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more